|
1
|
Hu Z, Zhou J, Xu X, Li Z, Zhou L, Wu J,
Zhang M and Zheng S: Salvage liver transplantation is a reasonable
option for selected patients who have recurrent hepatocellular
carcinoma after liver resection. PLoS One. 7:e365872012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang YY, Wang SJ, Yang LY, Lirng JF, Huang
CC, Liang JF, Lee FY, Hwang SJ, Huang CC and Kirby R: Effects of a
new parallel primary healthcare centre and on-campus training
programme on history taking, physical examination skills and
medical students' preparedness: A prospective comparative study in
Taiwan. BMJ Open. 7:e0162942017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cong WM, Bu H, Chen J, Dong H, Zhu YY,
Feng LH, Chen J and Committee G; Guideline Committee, : Practice
guidelines for the pathological diagnosis of primary liver cancer:
2015 update. World J Gastroenterol. 22:9279–9287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rojas A, Zhang P, Wang Y, Foo WC, Muñoz
NM, Xiao L, Wang J, Gores GJ, Hung MC and Blechacz B: A positive
TGF-β/c-KIT feedback loop drives tumor progression in advanced
primary liver cancer. Neoplasia. 18:371–386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Onitilo AA, Engel JM, Greenlee RT and
Mukesh BN: Breast cancer subtypes based on ER/PR and Her2
expression: Comparison of clinicopathologic features and survival.
Clin Med Res. 7:4–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rubin J, Ayoub N, Kaldas F and Saab S:
Management of recurrent hepatocellular carcinoma in liver
transplant recipients: A systematic review. Exp Clin Transplant.
10:531–543. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oliva MR and Saini S: Liver cancer
imaging: role of CT, MRI, US and PET. Cancer Imaging. 4:S42–S46.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Q, Shang W, Zeng C, Wang K, Liang X,
Chi C, Liang X, Yang J, Fang C and Tian J: Theranostic imaging of
liver cancer using targeted optical/MRI dual-modal probes.
Oncotarget. 8:32741–32751. 2017.PubMed/NCBI
|
|
9
|
Snowberger N, Chinnakotla S, Lepe RM,
Peattie J, Goldstein R, Klintmalm GB and Davis GL: Alpha
fetoprotein, ultrasound, computerized tomography and magnetic
resonance imaging for detection of hepatocellular carcinoma in
patients with advanced cirrhosis. Aliment Pharmacol Ther.
26:1187–1194. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dumitrescu CI, Gheonea IA, Săndulescu L,
Surlin V, Săftoiu A and Dumitrescu D: Contrast enhanced ultrasound
and magnetic resonance imaging in hepatocellular carcinoma
diagnosis. Med Ultrason. 15:261–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun X, Li RU, Zhang B, Yang Y and Cui Z:
Treatment of liver cancer of middle and advanced stages using
ultrasound-guided percutaneous ethanol injection combined with
radiofrequency ablation: A clinical analysis. Oncol Lett.
11:2096–2100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shi J, Liu TW, Chen J, Green D, Jaffray D,
Wilson BC, Wang F and Zheng G: Transforming a targeted porphyrin
theranostic agent into a PET imaging probe for cancer.
Theranostics. 1:363–370. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang L, Li GM, Zhu JY, Li Z, Li T and
Leng XS: Efficacy of sorafenib after liver transplantation in
patients with primary hepatic carcinoma exceeding the Milan
criteria: A preliminary study. OncoTargets Ther. 5:457–462. 2012.
View Article : Google Scholar
|
|
14
|
Malagari K, Pomoni M, Sotirchos VS,
Moschouris H, Bouma E, Charokopakis A, Kelekis AD, Koundouras D,
Filippiadis D, Chatziioannou A, et al: Long term recurrence
analysis post drug eluting bead (deb) chemoembolization for
hepatocellular carcinoma (hcc). Hepatogastroenterology.
60:1413–1419. 2013.PubMed/NCBI
|
|
15
|
Lee CH, Brubaker LM, Gerber DA, Ku YM, Kim
YH, Shin SS and Semelka RC: MRI findings of recurrent
hepatocellular carcinoma after liver transplantation: Preliminary
results. J Magn Reson Imaging. 33:1399–1405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Le Moigne F, Durieux M, Bancel B, Boublay
N, Boussel L, Ducerf C, Berthezène Y and Rode A: Impact of
diffusion-weighted MR imaging on the characterization of small
hepatocellular carcinoma in the cirrhotic liver. Magn Reson
Imaging. 30:656–665. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bruix J, Reig M and Sherman M:
Evidence-based diagnosis, staging, and treatment of patients with
hepatocellular carcinoma. Gastroenterology. 150:835–853. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu Z, Lv G, Li Y, Li E, Li H, Zhou Q, Yang
B and Cao W: Enhancement of anti-tumor effects of 5-fluorouracil on
hepatocellular carcinoma by low-intensity ultrasound. J Exp Clin
Cancer Res. 35:712016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Furlan A, Marin D, Cabassa P, Taibbi A,
Brunelli E, Agnello F, Lagalla R and Brancatelli G: Enhancement
pattern of small hepatocellular carcinoma (HCC) at
contrast-enhanced US (CEUS), MDCT, and MRI: Intermodality agreement
and comparison of diagnostic sensitivity between 2005 and 2010
American Association for the Study of Liver Diseases (AASLD)
guidelines. Eur J Radiol. 81:2099–2105. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wakayama K, Kamiyama T, Yokoo H, Orimo T,
Shimada S, Einama T, Kamachi H and Taketomi A: Huge hepatocellular
carcinoma greater than 10 cm in diameter worsens prognosis by
causing distant recurrence after curative resection. J Surg Oncol.
115:324–329. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang X, Wang D, Ma Y, Zhao Q, Fallon JK,
Liu D, Xu XE, Wang Y, He Z and Liu F: Theranostic nanoemulsions:
Codelivery of hydrophobic drug and hydrophilic imaging probe for
cancer therapy and imaging. Nanomedicine (Lond). 9:2773–2785. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Escartin A, Sapisochin G, Bilbao I,
Vilallonga R, Bueno J, Castells L, Dopazo C, Castro E, Caralt M and
Balsells J: Recurrence of hepatocellular carcinoma after liver
transplantation. Transplant Proc. 39:2308–2310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiao JD, Zhu WH and Shen SR: Evaluation of
hepatocellular carcinoma using contrast-enhanced ultrasonography:
Correlation with microvessel morphology. Hepatobiliary Pancreat Dis
Int. 9:605–610. 2010.PubMed/NCBI
|
|
24
|
Shagdarsuren B, Tamai H, Shingaki N, Mori
Y, Maeshima S, Nuta J, Maeda Y, Moribata K, Niwa T, Deguchi H, et
al: Contribution of contrast-enhanced sonography with
perfluorobutane microbubbles for diagnosis of recurrent
hepatocellular carcinoma. J Ultrasound Med. 35:1383–1391. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nörthen A, Asendorf T, Walson PD and
Oellerich M: Diagnostic value of alpha-1-fetoprotein (AFP) as a
biomarker for hepatocellular carcinoma recurrence after liver
transplantation. Clin Biochem. 52:20–25. 2018. View Article : Google Scholar : PubMed/NCBI
|
